Exclusive: Joel S. Hirschhorn predicts firms will switch from pushing vax to new antiviral meds
The unrelenting opposition to using ivermectin to treat and prevent COVID-19 is stronger than ever. This has resulted from a gigantic increase in demand for IVM by much of the public. Despite big media tirades against the medication, the truth about its effectiveness (together with failure of COVID vaccines) has reached the public through many articles on alternative news websites and truth-tellers on countless podcasts. Ivermectin’s success has forced Big Pharma to create expensive copies of it.
In my book “Pandemic Blunder,” I made the case with data that using cheap, safe and effective generics like IVM and hydroxychloroquine would prevent 80% or more of COVID deaths. Esteemed physician Dr. Peter McCollough later said 85%. For the U.S., that means over 500,000 lives could have been saved, and globally over 4 million lives. Meanwhile, hundreds of thousands of people worldwide have died from COVID vaccines, the failed solution to the pandemic.
Merck, a maker of IVM, is getting much positive press coverage for its forthcoming prescription oral antiviral (molnupiravir). It is designed to replace IVM, since they cannot make big money from ivermectin. The FDA will soon give molnupiravir emergency use authorization because of the emerging clarity that COVID vaccines do NOT work effectively or safely.
PROVES big time KICKBACKS for the POLITIANS, FAUCI< SOROS, BLOOMBERG, Gates and all the others pushing PHIZER.